Pentixapharm Holding AG Stock
Price
Target price
€1.73
€1.73
-3.080%
-0.054
-3.080%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Pentixapharm Holding
sharewise wants to provide you with the best news and tools for Pentixapharm Holding, so we directly link to the best financial data sources.
Financials
News
EQS-News: Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial
EQS-News: Pentixapharm Announces Advancement of PentixaTher to Fourth Dose Level in Acute Myeloid Leukemia Trial
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
EQS-Adhoc: Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
EQS-News: Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
EQS-News: Pentixapharm to Present First-in-Class Glycan-Dependent CD24 Antibody GT-008 for Solid Tumors at AACR 2025
EQS-News: Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE
EQS-News: Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based PentixaTher with Eckert & Ziegler SE
EQS-News: Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year
EQS-News: Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guidance for the 2025 Financial Year